Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gastric Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    June 2019
  1. LIU X, Lu Y, Xu Y, Hou S, et al
    Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
    Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30330.
    PubMed     Text format     Abstract available


    May 2019
  2. YUAN J, Yin Z, Tan L, Zhu W, et al
    Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
    Cancer Lett. 2019 May 9. pii: S0304-3835(19)30282.
    PubMed     Text format     Abstract available


  3. HU Y, Qi C, Liu X, Zhang C, et al
    Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Cancer Lett. 2019 May 7. pii: S0304-3835(19)30271.
    PubMed     Text format     Abstract available


    April 2019
  4. ZHAI J, Shen J, Xie G, Wu J, et al
    Cancer-associated Fibroblasts-derived IL-8 Mediates Resistance to Cisplatin in Human Gastric Cancer.
    Cancer Lett. 2019 Apr 9. pii: S0304-3835(19)30227.
    PubMed     Text format     Abstract available


    March 2019
  5. ZHAO C, Tao T, Yang L, Qin Q, et al
    Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.
    Cancer Lett. 2019 Mar 28. pii: S0304-3835(19)30199.
    PubMed     Text format     Abstract available


  6. DU F, Feng W, Chen S, Wu S, et al
    Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
    Cancer Lett. 2019 Mar 25. pii: S0304-3835(19)30191.
    PubMed     Text format     Abstract available


  7. ZHANG B, Ling T, Zhaxi P, Cao Y, et al
    Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
    Cancer Lett. 2019;452:23-30.
    PubMed     Text format     Abstract available


  8. HU Y, Liu JP, Li XY, Cai Y, et al
    Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin beta-1/NF-kappaB signaling pathway.
    Cancer Lett. 2019 Mar 5. pii: S0304-3835(19)30125.
    PubMed     Text format     Abstract available


    February 2019
  9. XU Z, Li Z, Wang W, Xia Y, et al
    MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
    Cancer Lett. 2019 Feb 16. pii: S0304-3835(19)30104.
    PubMed     Text format     Abstract available


  10. WANG Y, Wang K, Jin Y, Sheng X, et al
    Endoplasmic reticulum proteostasis control and gastric cancer.
    Cancer Lett. 2019 Feb 15. pii: S0304-3835(19)30054.
    PubMed     Text format     Abstract available


    December 2018
  11. GUO H, Ji F, Zhao X, Yang X, et al
    MicroRNA-371a-3p Promotes Progression of Gastric Cancer by Targeting TOB1.
    Cancer Lett. 2018 Dec 4. pii: S0304-3835(18)30687.
    PubMed     Text format     Abstract available


    November 2018
  12. XIE M, Ma T, Xue J, Ma H, et al
    The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR.
    Cancer Lett. 2018 Nov 28. pii: S0304-3835(18)30698.
    PubMed     Text format     Abstract available


  13. FANG J, Hong H, Xue X, Zhu X, et al
    A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus.
    Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30661.
    PubMed     Text format     Abstract available


    May 2018
  14. DING M, Wang H, Qu C, Xu F, et al
    Pyrazolo[1,5-a]pyrimidine TRPC6 Antagonists for the Treatment of Gastric Cancer.
    Cancer Lett. 2018 May 31. pii: S0304-3835(18)30380.
    PubMed     Text format     Abstract available


  15. MIN A, Eun Kim J, Kim YJ, Min Lim J, et al
    Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
    Cancer Lett. 2018 May 2. pii: S0304-3835(18)30310.
    PubMed     Text format     Abstract available


    February 2018
  16. ESPINOZA JL, Matsumoto A, Tanaka H, Matsumura I, et al
    Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.
    Cancer Lett. 2018;414:147-152.
    PubMed     Text format     Abstract available


    January 2018
  17. QIAO Y, Li T, Zheng S, Wang H, et al
    The Hippo pathway as a drug target in gastric cancer.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30095.
    PubMed     Text format     Abstract available


  18. MANU KA, Shanmugam MK, Ramachandran L, Li F, et al
    Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-kappaB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36].
    Cancer Lett. 2018 Jan 13. pii: S0304-3835(18)30025.
    PubMed     Text format    


  19. YUAN H, Chen Z, Bai S, Wei H, et al
    Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
    Cancer Lett. 2018 Jan 11. pii: S0304-3835(18)30054.
    PubMed     Text format     Abstract available


    November 2017
  20. YANG L, Zhang W, Wang Y, Zou T, et al
    Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells.
    Cancer Lett. 2017 Nov 9. pii: S0304-3835(17)30701.
    PubMed     Text format     Abstract available


    October 2017
  21. ZENG S, Xie X, Xiao YF, Tang B, et al
    Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression.
    Cancer Lett. 2017;412:179-187.
    PubMed     Text format     Abstract available


  22. DAS K, Taguri M, Imamura H, Sugimoto N, et al
    Genomic Predictors of Chemotherapy Efficacy in Advanced or Recurrent Gastric Cancer in the GC0301/ TOP002 Phase III Clinical Trial.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30645.
    PubMed     Text format     Abstract available


  23. WU QN, Liao YF, Lu YX, Wang Y, et al
    Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Cancer Lett. 2017 Oct 16. pii: S0304-3835(17)30631.
    PubMed     Text format     Abstract available


  24. CHEN J, Li GQ, Zhang L, Tang M, et al
    Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
    Cancer Lett. 2017 Oct 12. pii: S0304-3835(17)30626.
    PubMed     Text format     Abstract available


  25. GUO W, You X, Wang X, Wang L, et al
    A synthetic peptide hijacks the catalytic subunit of class I PI3K to suppress the growth of cancer cells.
    Cancer Lett. 2017;405:1-9.
    PubMed     Text format     Abstract available


    September 2017
  26. LI B, Wang W, Li Z, Chen Z, et al
    MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Cancer Lett. 2017 Sep 28. pii: S0304-3835(17)30596.
    PubMed     Text format     Abstract available


  27. LI Y, Huang S
    Response to Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Sep 26. pii: S0304-3835(17)30553.
    PubMed     Text format    


    August 2017
  28. ZHANG J, Zhu J
    Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Aug 26. pii: S0304-3835(17)30505.
    PubMed     Text format    


  29. MA DH, Li BS, Liu JJ, Xiao YF, et al
    miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30504.
    PubMed     Text format     Abstract available


  30. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available


  31. NORONHA V, Patil VM, Joshi A, Chougule A, et al
    Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Cancer Lett. 2017;400:267-275.
    PubMed     Text format     Abstract available


    July 2017
  32. RIBEIRO J, Malta M, Galaghar A, Silva F, et al
    P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Cancer Lett. 2017;404:37-43.
    PubMed     Text format     Abstract available


    June 2017
  33. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available


    May 2017
  34. LI Y, Huang S
    Response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 30. pii: S0304-3835(17)30330.
    PubMed     Text format    


  35. SUN Z, Liu J, Zhou Q, Yang S, et al
    Comment on "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 20. pii: S0304-3835(17)30331.
    PubMed     Text format    


    April 2017
  36. GEN Y, Yasui K, Kitaichi T, Iwai N, et al
    ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Cancer Lett. 2017 Apr 8. pii: S0304-3835(17)30232.
    PubMed     Text format     Abstract available


    March 2017
  37. LI Y, Wu Z, Yuan J, Sun L, et al
    Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Cancer Lett. 2017 Mar 4. pii: S0304-3835(17)30152.
    PubMed     Text format     Abstract available


    February 2017
  38. FERREIRA JA, Magalhaes A, Gomes J, Peixoto A, et al
    Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Cancer Lett. 2017;387:32-45.
    PubMed     Text format     Abstract available


  39. XU L, Zhou R, Yuan L, Wang S, et al
    IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30122.
    PubMed     Text format     Abstract available


  40. WU H, Liu S, Gong J, Liu J, et al
    VCPA, a novel synthetic derivative of alpha-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30107.
    PubMed     Text format     Abstract available


    January 2017
  41. TSAI MM, Wang CS, Tsai CY, Chen CY, et al
    Corrigendum to "MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer" [Cancer Lett 351 (2014) 222-231].
    Cancer Lett. 2017 Jan 27. pii: S0304-3835(17)30071.
    PubMed     Text format    


    December 2016
  42. MI Y, Zhang D, Jiang W, Weng J, et al
    miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30803.
    PubMed     Text format     Abstract available


  43. CHEN J, Li Y, Zheng Q, Bao C, et al
    Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.
    Cancer Lett. 2016;388:208-219.
    PubMed     Text format     Abstract available


    November 2016
  44. YUAN W, Liu B, Wang X, Li T, et al
    CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Cancer Lett. 2016 Nov 17. pii: S0304-3835(16)30703.
    PubMed     Text format     Abstract available


  45. LI R, Liu B, Gao J
    The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Cancer Lett. 2016 Nov 11. pii: S0304-3835(16)30663.
    PubMed     Text format     Abstract available


  46. WANG Z, Wang Z, Li G, Wu H, et al
    CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1/FAK/AKT signaling.
    Cancer Lett. 2016;385:28-38.
    PubMed     Text format     Abstract available


    October 2016
  47. HWANG DW, Bang NY, Ito K, Ha S, et al
    In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30661.
    PubMed     Text format     Abstract available


  48. PENG Y, Zhang X, Ma Q, Yan R, et al
    MiRNA-194 activates the Wnt/beta-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30666.
    PubMed     Text format     Abstract available


  49. WANG JB, Wang ZW, Li Y, Huang CQ, et al
    CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of beta-catenin signaling.
    Cancer Lett. 2016 Oct 25. pii: S0304-3835(16)30645.
    PubMed     Text format     Abstract available


    July 2016
  50. DU Y, Yu J, Du L, Tang J, et al
    Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
    Cancer Lett. 2016;376:240-8.
    PubMed     Text format     Abstract available


    June 2016
  51. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: